Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASF-1096 cream 0.5% in newly developed discoid lupus erythematosus lesions
2006-003780-30Phase 2Completed
- Sponsor
- Astion Pharma
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levalbuterol in discoid lupus erythematosus (DLE) (2 arms), sponsored by Astion Pharma. Started Aug 2006; status: completed.
02
Drugs
levalbuterol
03
Conditions
discoid lupus erythematosus (DLE)
Beyond the preview
Go deeper on 2006-003780-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003780-30.